OBJECTIVEObserve therapeutic effect of suspended moxibustion on temperature-sensitive acupoints for chronic prostatitis, to explore a new therapy.

METHODSSixty cases were randomly divided into an observation group and a control group (n = 30 in each group). The suspended moxibustion on temperature-sensitive acupoints plus herbalenema were practiced in the observation group. The moxibustion at Guanyuan (CV 4), Zhongji (CV 3), Shenshu (BL 23) combined with herbalenema were practiced in the control group. The score of syndromes, the score of symptom indexes (NIH-CPSI), and WBC in prostatic secretion (EPS-WBC) were used as observation index for chronic prostatitis. The therapeutic effect was compared between the two groups.

RESULTSThe markedly cured rate was 50.0% in the observation group, better than that of 26.7% in the control group (P < 0.05). The score of syndromes, NIH-CPSI and EPS-WBC in the observation group were lower than the control group (P < 0.05, P < 0.01).

CONCLUSIONThe therapeutic effect of suspended moxibustion on temperature-sensitive acupoints plus medication is better than moxibustion plus medication for chronic prostatitis in improvement of symptoms and EPS-WBC.

Acupuncture Points ; Adult ; Chronic Disease ; therapy ; Enema ; Humans ; Male ; Middle Aged ; Moxibustion ; Prostatitis ; drug therapy ; therapy ; Treatment Outcome ; Young Adult

Objective To investigate the changes of left ventricular structure and function in patients with liver cirrhosis and their correlation with the model for end-stage liver disease (MELD) score. Methods A total of 89 cirrhotic patients admitted between June, 2012 and June, 2014 and 30 healthy control subjects were enrolled in the study. According to MELD score, the cirrhotic patients were divided into 3 groups with MELD scores≤9, between 10 and 19, and≥20. The parameters of the left ventricle in resting state were measured using Doppler echocardiography, including left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), left atrial diameter (LAD), ejection fraction (LVEF), cardiac output (CO), mitral flow velocity, and E wave deceleration time (DT), and evaluated their relationship with MELD score. Results Compared with the control subjects, the cirrhotic patients showed significantly increased LVESD, LVEDD, IVST, LAD, CO and DT but reduced VE/VA ratio (P<0.05 or 0.01). The values of LVESD, LVEDD, IVST, LAD and DT increased gradually with MELD scores (P<0.05 or 0.01). VE/VA ratio was higher in patients with MELD score of 10-19 than in those with MELD score≤9, and decreased significantly in those with MELD score≥20. Of the cirrhotic patients, 55%were found to have left atrial enlargement and 44%had a VE/VA ratio≤1;left atrial enlargement and a VE/VA ratio below 1 were more common in patients with a MELD score≥20 than in those with lower MELD scores. The LAD, LVEDD and DT were positively correlated with MELD scores (r=0.208, 0.319 and 0.197, respectively;P<0.05 or 0.01). Conclusion The patients with liver cirrhosis can have cardiac function deficiency manifested mainly by left ventricular diastolic dysfunction in positive correlation with the severity of liver disease.

Objective To investigate the changes of left ventricular structure and function in patients with liver cirrhosis and their correlation with the model for end-stage liver disease (MELD) score. Methods A total of 89 cirrhotic patients admitted between June, 2012 and June, 2014 and 30 healthy control subjects were enrolled in the study. According to MELD score, the cirrhotic patients were divided into 3 groups with MELD scores≤9, between 10 and 19, and≥20. The parameters of the left ventricle in resting state were measured using Doppler echocardiography, including left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), left atrial diameter (LAD), ejection fraction (LVEF), cardiac output (CO), mitral flow velocity, and E wave deceleration time (DT), and evaluated their relationship with MELD score. Results Compared with the control subjects, the cirrhotic patients showed significantly increased LVESD, LVEDD, IVST, LAD, CO and DT but reduced VE/VA ratio (P<0.05 or 0.01). The values of LVESD, LVEDD, IVST, LAD and DT increased gradually with MELD scores (P<0.05 or 0.01). VE/VA ratio was higher in patients with MELD score of 10-19 than in those with MELD score≤9, and decreased significantly in those with MELD score≥20. Of the cirrhotic patients, 55%were found to have left atrial enlargement and 44%had a VE/VA ratio≤1;left atrial enlargement and a VE/VA ratio below 1 were more common in patients with a MELD score≥20 than in those with lower MELD scores. The LAD, LVEDD and DT were positively correlated with MELD scores (r=0.208, 0.319 and 0.197, respectively;P<0.05 or 0.01). Conclusion The patients with liver cirrhosis can have cardiac function deficiency manifested mainly by left ventricular diastolic dysfunction in positive correlation with the severity of liver disease.